Total Payments
$1,987
2024 Payments
$322.98
Companies
19
Transactions
95
Medicare Patients
765
Medicare Billing
$43,805
Payment Breakdown by Category
Food & Beverage$1,902 (95.7%)
Education$85.00 (4.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,902 | 94 | 95.7% |
| Education | $85.00 | 1 | 4.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $295.40 | 11 | $0 (2024) |
| ABBVIE INC. | $292.78 | 18 | $0 (2024) |
| Janssen Biotech, Inc. | $266.39 | 10 | $0 (2022) |
| Allergan, Inc. | $217.35 | 6 | $0 (2022) |
| Lilly USA, LLC | $179.77 | 8 | $0 (2022) |
| GENZYME CORPORATION | $135.69 | 6 | $0 (2024) |
| Sun Pharmaceutical Industries Inc. | $108.17 | 6 | $0 (2022) |
| PFIZER INC. | $84.12 | 5 | $0 (2022) |
| UCB, Inc. | $69.77 | 3 | $0 (2021) |
| MAYNE PHARMA COMMERCIAL LLC | $46.94 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $322.98 | 13 | Novartis Pharmaceuticals Corporation ($117.06) |
| 2023 | $81.66 | 7 | ABBVIE INC. ($55.84) |
| 2022 | $773.39 | 33 | Allergan, Inc. ($199.91) |
| 2021 | $809.36 | 42 | AbbVie Inc. ($167.39) |
All Payment Transactions
95 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/27/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: Dermatology | ||||||
| 11/22/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $7.52 | General |
| 11/14/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Dermatology | ||||||
| 11/10/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $117.06 | General |
| 11/08/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $35.36 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/15/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: Inflammation | ||||||
| 10/08/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $17.95 | General |
| Category: Immunology | ||||||
| 09/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: IMMUNOLOGY | ||||||
| 06/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $29.47 | General |
| Category: IMMUNOLOGY | ||||||
| 06/21/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $6.61 | General |
| 06/04/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: Immunology | ||||||
| 04/29/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Dermatology | ||||||
| 02/23/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $6.99 | General |
| 10/19/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: IMMUNOLOGY | ||||||
| 09/15/2023 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $6.62 | General |
| 08/11/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: IMMUNOLOGY | ||||||
| 05/12/2023 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $6.38 | General |
| 03/08/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: IMMUNOLOGY | ||||||
| 02/10/2023 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $6.15 | General |
| 01/27/2023 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $6.67 | General |
| 12/16/2022 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Immunology | ||||||
| 08/23/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: FACIAL AESTHETICS | ||||||
| 08/23/2022 | Sun Pharmaceutical Industries Inc. | BLU-U (Medical Supply), Odomzo | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: Dermatology | ||||||
| 08/15/2022 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $27.81 | General |
| Category: Immunology | ||||||
| 07/22/2022 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $6.56 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 179 | 312 | $32,541 | $10,859 |
| 2022 | 5 | 192 | 369 | $22,711 | $8,334 |
| 2021 | 10 | 283 | 592 | $45,010 | $18,407 |
| 2020 | 6 | 111 | 195 | $16,480 | $6,206 |
Total Patients
765
Total Services
1,468
Medicare Billing
$43,805
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 39 | 58 | $12,001 | $4,340 | 36.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 29 | 33 | $6,035 | $2,259 | 37.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 27 | 30 | $4,380 | $1,593 | 36.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 27 | 29 | $4,752 | $1,282 | 27.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 33 | 37 | $4,027 | $859.43 | 21.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 24 | 125 | $1,346 | $525.50 | 39.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 49 | 52 | $8,010 | $2,720 | 34.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 38 | 44 | $4,496 | $2,247 | 50.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 22 | 22 | $3,595 | $1,683 | 46.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 48 | 55 | $4,550 | $1,001 | 22.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 35 | 196 | $2,060 | $683.22 | 33.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 47 | 63 | $6,300 | $3,639 | 57.8% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 43 | 63 | $9,450 | $3,548 | 37.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 23 | 28 | $4,200 | $2,251 | 53.6% |
| 11301 | Shaving of 0.6 centimeters to 1.0 centimeters skin growth of the trunk, arms, or legs | Office | 2021 | 23 | 32 | $4,960 | $2,109 | 42.5% |
| 17004 | Destruction of 15 or more premalignant skin growths | Office | 2021 | 14 | 20 | $5,000 | $2,010 | 40.2% |
| 17000 | Destruction of skin growth | Office | 2021 | 47 | 62 | $4,960 | $1,372 | 27.7% |
| 17111 | Destruction of 15 or more non-cancerous skin growths | Office | 2021 | 17 | 21 | $3,780 | $1,293 | 34.2% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 43 | 271 | $2,168 | $1,008 | 46.5% |
| 11300 | Shaving of 0.5 centimeters or less skin growth of the trunk, arms, or legs | Office | 2021 | 14 | 20 | $2,500 | $725.32 | 29.0% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 12 | 12 | $1,692 | $452.27 | 26.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 31 | 34 | $5,100 | $2,066 | 40.5% |
| 17004 | Destruction of 15 or more skin growths | Office | 2020 | 11 | 14 | $3,500 | $1,329 | 38.0% |
| 17110 | Destruction of up to 14 skin growths | Office | 2020 | 17 | 20 | $3,000 | $1,257 | 41.9% |
| 17111 | Destruction of 15 or more skin growths | Office | 2020 | 11 | 12 | $2,160 | $822.88 | 38.1% |
About Katherine Parks
Katherine Parks is a Family healthcare provider based in Rochester, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/29/2008. The National Provider Identifier (NPI) number assigned to this provider is 1629236302.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Katherine Parks has received a total of $1,987 in payments from pharmaceutical and medical device companies, with $322.98 received in 2024. These payments were reported across 95 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($1,902).
As a Medicare-enrolled provider, Parks has provided services to 765 Medicare beneficiaries, totaling 1,468 services with total Medicare billing of $43,805. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Rochester, NY
- Active Since 05/29/2008
- Last Updated 12/23/2015
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1629236302
Products in Payments
- TREMFYA (Drug) $266.39
- SKYRIZI (Biological) $187.92
- TALTZ (Drug) $179.77
- COSENTYX (Biological) $178.34
- BOTOX (Biological) $170.95
- DUPIXENT (Biological) $147.29
- EUCRISA (Drug) $84.12
- RINVOQ (Biological) $73.28
- Cimzia (Drug) $69.77
- Ilumya (Biological) $57.18
- Zoryve (Drug) $46.46
- ORACEA (Drug) $44.74
- Otezla (Drug) $43.13
- ILUMYA (Biological) $37.60
- AMZEEQ (Drug) $36.64
- SPEVIGO (Drug) $29.47
- LIBTAYO (Biological) $23.76
- OPZELURA (Drug) $18.71
- ARAZLO (Drug) $18.55
- Sotyktu (Drug) $17.95
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Rochester
Stephanie Bakker, Np, NP
Family — Payments: $41,839
Family $41,839
Dr. Sheldon Fields, Phd, Fnp, PHD, FNP
Family — Payments: $19,816
Family $19,816
Freda Hannafon, N.p, N.P
Family — Payments: $16,956
Family $16,956
Ms. Kelly Farrow, Np, NP
Family — Payments: $12,058
Family $12,058
Lucy Holmes
Family — Payments: $10,743
Family $10,743
Hillary Mcconnell, Fnp, FNP
Family — Payments: $9,398
Family $9,398